180 related articles for article (PubMed ID: 24151765)
1. Gal-knockout bioprostheses exhibit less immune stimulation compared to standard biological heart valves.
McGregor CG; Kogelberg H; Vlasin M; Byrne GW
J Heart Valve Dis; 2013 May; 22(3):383-90. PubMed ID: 24151765
[TBL] [Abstract][Full Text] [Related]
2. Human antibody recognition of xenogeneic antigens (NeuGc and Gal) on porcine heart valves: could genetically modified pig heart valves reduce structural valve deterioration?
Lee W; Long C; Ramsoondar J; Ayares D; Cooper DK; Manji RA; Hara H
Xenotransplantation; 2016 Sep; 23(5):370-80. PubMed ID: 27511593
[TBL] [Abstract][Full Text] [Related]
3. Anti-alpha-Gal antibody response following xenogeneic heart valve implantation in adults.
Park CS; Oh SS; Kim YE; Choi SY; Lim HG; Ahn H; Kim YJ
J Heart Valve Dis; 2013 Mar; 22(2):222-9. PubMed ID: 23798212
[TBL] [Abstract][Full Text] [Related]
4. Physical equivalency of wild type and galactose α 1,3 galactose free porcine pericardium; a new source material for bioprosthetic heart valves.
McGregor C; Byrne G; Rahmani B; Chisari E; Kyriakopoulou K; Burriesci G
Acta Biomater; 2016 Sep; 41():204-209. PubMed ID: 27268480
[TBL] [Abstract][Full Text] [Related]
5. Reducing immunoreactivity of porcine bioprosthetic heart valves by genetically-deleting three major glycan antigens, GGTA1/β4GalNT2/CMAH.
Zhang R; Wang Y; Chen L; Wang R; Li C; Li X; Fang B; Ren X; Ruan M; Liu J; Xiong Q; Zhang L; Jin Y; Zhang M; Liu X; Li L; Chen Q; Pan D; Li R; Cooper DKC; Yang H; Dai Y
Acta Biomater; 2018 May; 72():196-205. PubMed ID: 29631050
[TBL] [Abstract][Full Text] [Related]
6. Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves.
McGregor CG; Carpentier A; Lila N; Logan JS; Byrne GW
J Thorac Cardiovasc Surg; 2011 Jan; 141(1):269-75. PubMed ID: 21168032
[TBL] [Abstract][Full Text] [Related]
7. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses.
Naso F; Gandaglia A; Bottio T; Tarzia V; Nottle MB; d'Apice AJ; Cowan PJ; Cozzi E; Galli C; Lagutina I; Lazzari G; Iop L; Spina M; Gerosa G
Xenotransplantation; 2013; 20(4):252-61. PubMed ID: 23865597
[TBL] [Abstract][Full Text] [Related]
8. Differences in xenoreactive immune response and patterns of calcification of porcine and bovine tissues in α-Gal knock-out and wild-type mouse implantation models.
Kim MS; Jeong S; Lim HG; Kim YJ
Eur J Cardiothorac Surg; 2015 Sep; 48(3):392-9. PubMed ID: 25549993
[TBL] [Abstract][Full Text] [Related]
9. Correlations between the alpha-Gal antigen, antibody response and calcification of cardiac valve bioprostheses: experimental evidence obtained using an alpha-Gal knockout mouse animal model.
Naso F; Colli A; Zilla P; Calafiore AM; Lotan C; Padalino MA; Sturaro G; Gandaglia A; Spina M
Front Immunol; 2023; 14():1210098. PubMed ID: 37426661
[TBL] [Abstract][Full Text] [Related]
10. Alpha-Gal Inactivated Heart Valve Bioprostheses Exhibit an Anti-Calcification Propensity Similar to Knockout Tissues.
Naso F; Stefanelli U; Buratto E; Lazzari G; Perota A; Galli C; Gandaglia A
Tissue Eng Part A; 2017 Oct; 23(19-20):1181-1195. PubMed ID: 29053434
[TBL] [Abstract][Full Text] [Related]
11. Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery.
Konakci KZ; Bohle B; Blumer R; Hoetzenecker W; Roth G; Moser B; Boltz-Nitulescu G; Gorlitzer M; Klepetko W; Wolner E; Ankersmit HJ
Eur J Clin Invest; 2005 Jan; 35(1):17-23. PubMed ID: 15638815
[TBL] [Abstract][Full Text] [Related]
12. The α-Gal KO Mouse Animal Model is a Reliable and Predictive Tool for the Immune-Mediated Calcification Assessment of Heart Valve Bioprostheses.
Naso F; Gandaglia A; Sturaro G; Galli C; Melder RJ
Front Biosci (Landmark Ed); 2024 May; 29(5):181. PubMed ID: 38812319
[TBL] [Abstract][Full Text] [Related]
13. The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse.
Sung Jeong W; Jin Kim Y; Lim HG; Jung S; Ryul Lee J
J Heart Valve Dis; 2016 Mar; 25(2):253-261. PubMed ID: 27989076
[TBL] [Abstract][Full Text] [Related]
14. Alpha-Gal specific IgG immune response after implantation of bioprostheses.
Mangold A; Szerafin T; Hoetzenecker K; Hacker S; Lichtenauer M; Niederpold T; Nickl S; Dworschak M; Blumer R; Auer J; Ankersmit HJ
Thorac Cardiovasc Surg; 2009 Jun; 57(4):191-5. PubMed ID: 19670109
[TBL] [Abstract][Full Text] [Related]
15. Identification of human preformed antibody targets in GTKO pigs.
Burlak C; Wang ZY; Chihara RK; Lutz AJ; Wang Y; Estrada JL; Tector AJ
Xenotransplantation; 2012; 19(2):92-101. PubMed ID: 22497511
[TBL] [Abstract][Full Text] [Related]
16. Biological Equivalence of GGTA-1 Glycosyltransferase Knockout and Standard Porcine Pericardial Tissue Using 90-Day Mitral Valve Implantation in Adolescent Sheep.
McGregor C; Salmonsmith J; Burriesci G; Byrne G
Cardiovasc Eng Technol; 2022 Jun; 13(3):363-372. PubMed ID: 34820778
[TBL] [Abstract][Full Text] [Related]
17. Anti alpha-gal immune response following porcine bioprosthesis implantation in children.
Park CS; Park SS; Choi SY; Yoon SH; Kim WH; Kim YJ
J Heart Valve Dis; 2010 Jan; 19(1):124-30. PubMed ID: 20329498
[TBL] [Abstract][Full Text] [Related]
18. Genetically engineered sheep: A new paradigm for future preclinical testing of biological heart valves.
McGregor CGA; Byrne GW; Fan Z; Davies CJ; Polejaeva IA
J Thorac Cardiovasc Surg; 2023 Oct; 166(4):e142-e152. PubMed ID: 36914518
[TBL] [Abstract][Full Text] [Related]
19. Effect of αGal on corneal xenotransplantation in a mouse model.
Choi HJ; Kim MK; Lee HJ; Jeong SH; Kang HJ; Park CS; Park CG; Joon Kim S; Wee WR
Xenotransplantation; 2011; 18(3):176-82. PubMed ID: 21696447
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin from alpha 1,3-galactosyltransferase knockout pigs is a xenoantigen.
Chihara RK; Lutz AJ; Paris LL; Wang ZY; Sidner RA; Heyrman AT; Downey SM; Burlak C; Tector AJ
J Surg Res; 2013 Oct; 184(2):1123-33. PubMed ID: 23673165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
